Table 1

Baseline demographic and clinical characteristics of 226 patients with recurrent depression receiving mindfulness-based cognitive therapy who subsequently engaged in full, partial or no discontinuation of maintenance antidepressant medication (mADM) (adapted from Huijbers et al, 2016)

Variable	Total N=226*						Sig.
	Full discontinuation (n=110)		Partial discontinuation (n=34)		No discontinuation (n=82)		Sig.
	N	%	N	%	N	%	P value
Female	62	76	18	53	71	64	0.048
Educational level							0.421
Low	7	9	3	9	6	6
Middle	24	29	10	29	31	28
High	49	60	21	62	64	58
Missing	2	2	0	0	9	8
Marital status							0.560
Single	19	23	6	18	27	25
Married/cohabiting	46	56	22	65	60	55
Divorced/widowed	15	18	6	18	16	15
Missing	2	2	0	0	7	6
Employed (n=225)	63	78	22	65	62	56	0.009
Remission							0.069
Full, IDS-C ≤11	51	62	17	50	50	45
Partial, IDS-C >11	31	38	17	50	60	55
Type of mADM							0.669
SSRI	64	78	23	68	21	19
TCA	13	16	7	21	21	19
Other†	5	6	4	12	6	6
Previous CBT treatment	45	55	21	62	68	62	0.595
Suicide attempt (lifetime)	18	22	12	15	21	49	0.429
	Mean	SD	Mean	SD	Mean	SD
Age (years)	50.0	11.1	52.0	9.8	51.0	10.3	0.507
Baseline depression (IDS-C)	10.9	8.8	12.7	11.2	14.4	10.6	0.059
Nr. previous episodes	5.6	4.9	7.4	8.0	5.7	3.9	0.167
Age at MDD onset (n=219)	27	11.9	25	10.8	25.0	12.3	0.388

*Excluding 23 of the original 249 trial participants due to missing data regarding discontinuation.
†Including serotonin-norepinephrine reuptake inhibitors, monoamine oxidase-inhibitors and mirtazapine.
CBT, cognitive behavioural therapy; IDS-C, Inventory of Depressive Symptomatology-clinician rated; MDD, major depressive disorder; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.